Exact Sciences Q1 2024 GAAP EPS $(0.60) Misses $(0.48) Estimate, Sales $638.000M Beat $627.365M Estimate
Exact Sciences Q1 2024 GAAP EPS $(0.60) Misses $(0.48) Estimate, Sales $638.000M Beat $627.365M Estimate
Exact Sciences 2024年第一季度GAAP每股收益美元（0.60）未达到预期（0.48），销售额6.38亿美元超过6.27365亿美元的预期
Exact Sciences (NASDAQ:EXAS) reported quarterly losses of $(0.60) per share which missed the analyst consensus estimate of $(0.48) by 25 percent. The company reported quarterly sales of $638.000 million which beat the analyst consensus estimate of $627.365 million by 1.70 percent. This is a 5.90 percent increase over sales of $602.450 million the same period last year.
Exact Sciences（纳斯达克股票代码：EXAS）公布的季度亏损为每股0.60美元，比分析师普遍预期的0.48美元（0.48美元）低25％。该公司公布的季度销售额为6.38亿美元，比分析师普遍预期的6.27365亿美元高出1.70％。这比去年同期的6.0245亿美元销售额增长了5.90％。